122 related articles for article (PubMed ID: 2552752)
1. Hepatitis B virus markers in patients with schistosomiasis, liver cirrhosis and hepatocellular carcinoma in Khartoum, Sudan.
Itoshima T; Fedail SS; Suliman I; Ali AK; Higashi T; Tsuji T
Acta Med Okayama; 1989 Aug; 43(4):241-4. PubMed ID: 2552752
[TBL] [Abstract][Full Text] [Related]
2. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
Swenson PD; Escobar MR; Silverman JF
Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
[TBL] [Abstract][Full Text] [Related]
4. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
[TBL] [Abstract][Full Text] [Related]
5. [Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].
Pedreira JD; Vargas V; Vilaseca J; Esteban R; Hernández-Sánchez JM; Guardia J; Bacardi R
Med Clin (Barc); 1980 Jun; 75(2):58-60. PubMed ID: 6249978
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of hepatitis B virus infection in chronic liver disease and hepatocellular carcinoma.
de Franchis R; Primignani M; Vecchi M; Antoniozzi F; Colombo M; Colucci G; Tommasini M
Ric Clin Lab; 1984; 14(1):81-8. PubMed ID: 6328629
[TBL] [Abstract][Full Text] [Related]
7. [Frequency of the detection of hepatitis A and B viral markers in blood donors in the Moldavian SSR].
Tsybuliak SN
Vopr Virusol; 1988; 33(1):89-92. PubMed ID: 2835875
[No Abstract] [Full Text] [Related]
8. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
9. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus.
Blumberg BS
Public Health Rep; 1980; 95(5):427-35. PubMed ID: 6252570
[No Abstract] [Full Text] [Related]
11. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
12. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
14. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma.
Colombo M; Rumi MG; Donato MF; Tommasini MA; Del Ninno E; Ronchi G; Kuo G; Houghton M
Dig Dis Sci; 1991 Aug; 36(8):1130-3. PubMed ID: 1650689
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
17. Anti-HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: relation to multitransfusion.
Chang WY; Wang LY; Chuang WL; Chen SC; Lu SN; You SL
J Gastroenterol Hepatol; 1992; 7(2):128-31. PubMed ID: 1315166
[TBL] [Abstract][Full Text] [Related]
18. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
Jiang MD
Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the humoral markers associated with hepatitis B virus in hepatocellular carcinoma patients and in subjects with chronic hepatopathy].
de Franchis R; Primignani M; Vecchi M; Zannier PM; Colombo M; Colucci G; Antoniozzi F; Tommasini M
Ann Sclavo; 1982; 24(1):37-48. PubMed ID: 6303232
[No Abstract] [Full Text] [Related]
20. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
